The Role of Serum Interleukin-6 Levels in Prognosticating Postoperative Complications After Cytoreductive Surgery for Ovarian Cancers: A Prospective Observational Study

Vibhavari Naik; Rajagopalan Iyer; Basanth Kumar Rayani; Dandamudi Radha Rani; Devi Chaitanya BS; Subramanyeshwar Rao Thammineedi

Journal of Cellular & Molecular Anesthesia

Journal Information Editors & Boards Indexing and Listing Sources Journal Metrics Open Peer Review (OPR)Publication Ethics and Malpractice Statement New Publisher Announcement Reviewer and AE Registration Form Contact Us Support

APC

Authors Guide Submit Manuscript

The Role of Serum Interleukin-6 Levels in Prognosticating Postoperative Complications After Cytoreductive Surgery for Ovarian Cancers: A Prospective Observational Study

Author(s):

Vibhavari Naik^1,*,

Rajagopalan Iyer²,

Basanth Kumar Rayani³,

Dandamudi Radha Rani⁴,

Devi Chaitanya BS⁴,

Subramanyeshwar Rao Thammineedi²

1Basavatarakam Indo-American Cancer Hospital and Research Institute, Hyderabad, India.

2Department of Surgical Oncology, Basavatarakam Indo-American Cancer Hospital and Research Institute, Hyderabad, India. 500034.

3Department of Oncoanaesthesiology, Pain and Palliative Medicine, Basavatarakam Indo-American Cancer Hospital and Research Institute, Hyderabad. 500034.

4Department of Microbiology, Basavatarakam Indo-American Cancer Institute and Research Center, Hyderabad, India. 500034.

Journal of Cellular & Molecular Anesthesia:Vol. 8, issue 3; e149152

Published online:Feb 26, 2023

Article type:Original Articles_ojs_imported

Received:Oct 24, 2022

Accepted:Dec 04, 2022

How to Cite:Vibhavari NaikRajagopalan IyerBasanth Kumar RayaniDandamudi Radha RaniDevi Chaitanya BSSubramanyeshwar Rao Thammineediet al.The Role of Serum Interleukin-6 Levels in Prognosticating Postoperative Complications After Cytoreductive Surgery for Ovarian Cancers: A Prospective Observational Study.J Cell Mol Anesth.8(3):e149152.

Abstract

Background: Interleukin-6 (IL-6), a pro-inflammatory cytokine, has been associated with adverse prognosis in ovarian cancer. Cytoreductive surgery for ovarian cancer has a higher risk of postoperative surgical complications (POCs). We aimed to find out if serum IL-6 is elevated preoperatively in patients undergoing cytoreductive surgery for ovarian cancer and if it can predict POCs. We also compared its trend with serum C-reactive protein (CRP) in the early postoperative period. Materials and Methods: Fifty-one patients between 18?75 years, posted for elective ovarian cytoreductive surgery at a tertiary cancer hospital were included after taking informed consent. Serum IL-6 and CRP were done the day before surgery and repeated 24 and 72 hours post-surgery. All parameters that affect POCs were captured. POCs were graded using the Clavein Dindo classification. We recorded the length of the intensive care unit (ICU), hospital stay, and 30-day mortality. Appropriate statistical tests were used and p value <0.05 was considered significant. Results:?Out of 51 enrolled patients, 46 were included for data analysis after exclusions. The mean age of patients in this study was 49.76 +/- 12.42 years with a mean surgical duration of 302.39 +/- 127.04 minutes and mean blood loss of 332.6 +/- 274.71 mL. The incidence of POCs in our study was 21.7% (10/46 patients). Preoperative IL-6 was raised and was able to predict POCs with 70% sensitivity and 86% specificity at a cutoff value of 23.56 pg./mL (R2 = 0.71; AUC = 0.79). In patients who developed POCs, IL-6 values (1196.7+/-1461.4 pg./mL) peaked at 24 hours whereas CRP values (360 +/- 430.1 mg/L) peaked at 72 hours; thus, allowing early prognostication with IL-6. The cut-off value of serum IL-6 at 24 hours to predict POCs is 480 pg./mL (R2 = 0.50; AUC = 0.79) with 80% sensitivity and 89% specificity. Two patients died - on postoperative days 5 and 28 respectively. Conclusion: Preoperative IL-6 is raised in patients with ovarian cancer posted for cytoreductive surgery. A cut-off value of 23.56 pg./mL preoperatively and 480 pg./mL at 24 hours after surgery could predict postoperative surgical complications.

Keywords

Interleukin-6

C-reactive protein

Ovarian cancer

Postoperative complications

References

1.
References are in the PDF file of the article.

comments